Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Context Capital Management
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Context Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $15B | 15M | 1016.90 |
| 2023-09-30 | $25M | 22k | 1121.13 |
More positions owned by Context Capital Management
View all positions for Context Capital Management
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1